{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:36:50Z","timestamp":1784867810416,"version":"3.55.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Ophthalmol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Zoledronate is a commonly prescribed medication to maintain bone health; however, a rare side effect includes ocular inflammation. We report a case of simultaneous anterior uveitis and orbital inflammation associated with zoledronate infusion in a patient with metastatic breast cancer. We also performed a literature search to provide an up-to-date summary of cases with zoledronate-associated ocular inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a case report with literature review. Literature search (timeline 2010 to 2023) was performed using PubMed with the search team: (zoledronate) AND (uveitis OR scleritis OR orbital inflammation OR ocular inflammation).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A 48-year-old female presented with left eye pain, swelling, and decreased vision 2 days after receiving zoledronic acid infusion. An ophthalmic exam showed non-granulomatous anterior uveitis. CT orbits and ocular ultrasound showed signs of posterior scleritis and orbital inflammation. Ocular inflammation caused by an infection or metastatic cancer was ruled out. The patient was treated with both topical and systemic corticosteroids. Complete resolution of the inflammation occurred after 2.5 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Orbital inflammation and uveitis are an uncommon side effect of zoledronate but needs to be promptly recognized and treated to prevent sight-threatening complications.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fopht.2024.1372429","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T05:10:06Z","timestamp":1713935406000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case report: A severe case of zoledronate-associated diffuse orbital inflammation and uveitis in a patient with metastatic breast cancer"],"prefix":"10.3389","volume":"4","author":[{"given":"Pushpinder","family":"Kanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaura","family":"Guerrero-C\u00f3rdova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jobanpreet","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"B1","volume-title":"Bisphosphonate","author":"Ganesan","year":"2023"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14063","article-title":"Aminobisphosphonate-associated orbital and ocular inflammatory disease","volume":"97","author":"Keren","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.03.006","article-title":"Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis)","volume":"148","author":"Grover","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037638","article-title":"Macular thickness by age and gender in healthy eyes using spectral domain optical coherence tomography","volume":"7","author":"Adhi","year":"2012","journal-title":"PloS One"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029692","article-title":"Scleral thickness in human eyes","volume":"7","author":"Vurgese","year":"2012","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X14566424","article-title":"Inflammatory eye reactions with bisphosphonates and other osteoporosis medications: what are the risks","volume":"7","author":"Clark","year":"2015","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1783","article-title":"Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database","volume":"28","author":"Pazianas","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01840-8","article-title":"Scleritis and other ocular side effects associated with pamidronate disodium","volume":"135","author":"Fraunfelder","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.9.1335","article-title":"Orbital inflammatory disease after pamidronate treatment for metastatic prostate cancer","volume":"121","author":"Subramanian","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31816576ef","article-title":"Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort","volume":"28","author":"French","year":"2008","journal-title":"Retina"},{"key":"B11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5693\/djo.02.2017.08.002","article-title":"Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature","volume":"23","author":"Umunakwe","year":"2017","journal-title":"Digit J Ophthalmol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3109\/01676830.2011.648818","article-title":"Bisphosphonate-associated orbital inflammation\u2013a case report and review","volume":"31","author":"Peterson","year":"2012","journal-title":"Orbit"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2012.09.011","article-title":"Orbital inflammation after zoledronate infusion: an emerging complication","volume":"48","author":"Rahimy","year":"2013","journal-title":"Can J Ophthalmol"},{"key":"B14","article-title":"Ocular inflammation associated with alendronate therapy","volume":"117","author":"Mbekeani","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-2035-z","article-title":"Risedronate-associated scleritis: a case report and review of the literature","volume":"31","author":"Hemmati","year":"2012","journal-title":"Clin Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200303203481225","article-title":"Bisphosphonates and ocular inflammation","volume":"348","author":"Fraunfelder","year":"2003","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-1-4419-1050-9_2","article-title":"Activation of gammadelta T cells by bisphosphonates","volume":"658","author":"Thompson","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300603","article-title":"Essential requirements of zoledronate-induced cytokine and gammadelta T cell proliferative responses","volume":"191","author":"Nussbaumer","year":"2013","journal-title":"J Immunol"},{"key":"B19","article-title":"Orbital inflammation after use of zoledronic acid for metastasized prostate carcinoma","volume":"315","author":"Missotten","year":"2010","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"B20","article-title":"Zolendronate associated inflammatory orbital disease","volume":"123","author":"Yeo","year":"2010","journal-title":"N Z Med J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4158\/EP11081.CR","article-title":"Orbital inflammatory disease in a patient treated with zoledronate","volume":"17","author":"Kaur","year":"2011","journal-title":"Endocr Pract"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3109\/01676830.2010.535641","article-title":"Two cases of drug-induced orbital inflammatory disease","volume":"30","author":"Ortiz-Perez","year":"2011","journal-title":"Orbit"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2012.03.020","article-title":"Acute anterior uveitis following zoledronic acid infusion for osteoporosis","volume":"47","author":"Belliveau","year":"2012","journal-title":"Can J Ophthalmol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1328337","article-title":"Bisphosphonate-associated orbital inflammatory disease and uveitis anterior\u2013a case report and review","volume":"230","author":"Boni","year":"2013","journal-title":"Klin Monbl Augenheilkd"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3109\/08820538.2013.839806","article-title":"Unilateral uveitis with vitreous haze following zoledronic Acid therapy for osteoporosis","volume":"30","author":"Freitas-Neto","year":"2015","journal-title":"Semin Ophthalmol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e31829f3b46","article-title":"Nitrogen bisphosphonate-induced orbital inflammatory disease: gamma delta T cells\u2013a report and review of 2 cases","volume":"30","author":"Vora","year":"2014","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"B27","article-title":"[Acute anterior uveitis associated with the use zoledronic acid]","volume":"74","author":"Cavallasca","year":"2014","journal-title":"Medicina (B Aires)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/RHU.0000000000000433","article-title":"Orbital inflammation secondary to zoledronic acid, a rare presentation","volume":"22","author":"Muruganandam","year":"2016","journal-title":"J Clin Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12891-016-0926-x","article-title":"Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report","volume":"17","author":"Tian","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2014.942747","article-title":"A case series and review of bisphosphonate-associated orbital inflammation","volume":"24","author":"Lefebvre","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2016.4921","article-title":"Bilateral ocular pain and hyperemia in a patient with Paget disease of the bone","volume":"135","author":"Haider","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2017.0018","article-title":"Acute bilateral anterior uveitis after a single intravenous infusion of zoledronic acid in metastatic breast cancer","volume":"31","author":"Jun","year":"2017","journal-title":"Korean J Ophthalmol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afy070","article-title":"Two case reports of zoledronic acid-induced uveitis","volume":"47","author":"Kennedy","year":"2018","journal-title":"Age Ageing"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-019-04850-w","article-title":"Bisphosphonate-induced orbital inflammation: more common than once thought","volume":"30","author":"Chehade","year":"2019","journal-title":"Osteoporos Int"},{"key":"B35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12886-019-1063-8","article-title":"Bisphosphonate-induced orbital inflammation in a patient on chronic immunosuppressive therapy","volume":"19","author":"Herrera","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/1078155218785967","article-title":"Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma","volume":"25","author":"Tan","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.13659","article-title":"Zoledronic acid associated orbital inflammation","volume":"48","author":"Han","year":"2020","journal-title":"Clin Exp Ophthalmol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1654_19","article-title":"Zoledronic acid induced unilateral anterior uveitis","volume":"68","author":"Gupta","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2050313X20944305","DOI":"10.1177\/2050313X20944305","article-title":"Acute unilateral anterior uveitis following zoledronic acid infusion: A case report","volume":"8","author":"Anandasayanan","year":"2020","journal-title":"SAGE Open Med Case Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-245359","article-title":"Zoledronic acid-induced orbital inflammation","volume":"14","author":"Khalid","year":"2021","journal-title":"BMJ Case Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1745245","article-title":"Acute bilateral anterior uveitis following cyclophosphamide\/bortezomid\/dexamethasone (CyBorD) protocol in a newly diagnosed multiple myeloma patient with concomitant use of zoledronic acid","volume":"29","author":"Karmiris","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"B42","doi-asserted-by":"publisher","first-page":"6647277","DOI":"10.1155\/2021\/6647277","article-title":"Keeping an eye on bisphosphonate therapy in myeloma: A case report of ocular inflammation postzoledronic acid infusion","volume":"2021","author":"Faryal","year":"2021","journal-title":"Case Rep Hematol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11657-021-00964-z","article-title":"Zoledronate-induced acute anterior uveitis: a three-case report and brief review of literature","volume":"16","author":"Jin","year":"2021","journal-title":"Arch Osteoporos"},{"key":"B44","article-title":"Zoledronate-induced anterior uveitis, scleritis and optic neuritis: a case report","volume":"134","author":"Wolpert","year":"2021","journal-title":"N Z Med J"},{"key":"B45","doi-asserted-by":"publisher","first-page":"105445","DOI":"10.1016\/j.jbspin.2022.105445","article-title":"Zoledronic acid-induced posterior scleritis associated with inflammatory orbitopathy","volume":"89","author":"Larid","year":"2022","journal-title":"Joint Bone Spine"},{"key":"B46","article-title":"[Bisphosphonate-induced ocular and orbital inflammation]","volume":"184","author":"Jakobsen","year":"2022","journal-title":"Ugeskr Laeger"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-023-01870-0","article-title":"[Acute unilateral fibrinous anterior uveitis after zoledronic acid infusion]","volume":"121","author":"Kaiser","year":"2023","journal-title":"Ophthalmologie"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000001503","article-title":"Uveitis, a rare but important complication of adjuvant zoledronic acid for early-stage breast cancer","volume":"34","author":"Chacko","year":"2023","journal-title":"Anticancer Drugs"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43162","article-title":"Acute iridocyclitis associated with intravenous zoledronic acid: a case report","volume":"15","author":"Ankireddypalli","year":"2023","journal-title":"Cureus"},{"key":"B50","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00198-014-2872-5","article-title":"Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial","volume":"26","author":"Patel","year":"2015","journal-title":"Osteoporos Int"},{"key":"B51","first-page":"U1888","article-title":"Drug-induced optic neuritis and uveitis secondary to bisphosphonates","volume":"119","author":"Stack","year":"2006","journal-title":"N Z Med J"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2008.tb02091.x","article-title":"Misdiagnosis of acute eye diseases by primary health care providers: incidence and implications","volume":"189","author":"Statham","year":"2008","journal-title":"Med J Aust"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.111752","article-title":"Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study","volume":"184","author":"Etminan","year":"2012","journal-title":"CMAJ"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.10.010","article-title":"Uveitis: Diagnostic work-up. A literature review and recommendations from an expert committee","volume":"16","author":"Seve","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1586\/eop.11.47","article-title":"Practical diagnostic approach to uveitis","volume":"6","author":"Grillo","year":"2011","journal-title":"Expert Rev Ophthalmol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.114092","article-title":"Algorithmic approach in the diagnosis of uveitis","volume":"61","author":"Rathinam","year":"2013","journal-title":"Indian J Ophthalmol"},{"key":"B57","volume-title":"Orbital Cellulitis","author":"Danishyar","year":"2024"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.18502\/jovr.v17i1.10176","article-title":"Orbital inflammation caused by aminobisphosphonates","volume":"17","author":"Gonzalez Barlatay","year":"2022","journal-title":"J Ophthalmic Vis Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12823","article-title":"Pain flare-effect prophylaxis with corticosteroids on bone radiotherapy treatment: A systematic review","volume":"20","author":"Fabregat","year":"2020","journal-title":"Pain Pract"},{"key":"B60","volume-title":"Corticosteroid Adverse Effects","author":"Yasir","year":"2024"},{"key":"B61","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00223-015-0015-4","article-title":"The effects of re-challenge in patients with a history of acute anterior uveitis following intravenous zoledronate","volume":"97","author":"Patel","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2007.17","article-title":"Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma","volume":"126","author":"Phillips","year":"2008","journal-title":"Arch Ophthalmol"}],"container-title":["Frontiers in Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2024.1372429\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T05:10:14Z","timestamp":1713935414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2024.1372429\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":62,"alternative-id":["10.3389\/fopht.2024.1372429"],"URL":"https:\/\/doi.org\/10.3389\/fopht.2024.1372429","relation":{},"ISSN":["2674-0826"],"issn-type":[{"value":"2674-0826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"article-number":"1372429"}}